AgingResearch.News

Cancer

Disease18 papers3 findings

Reviews link clonal haematopoiesis and epigenetic alterations to human cancer risk, while one in silico study suggests p53-dependent LAMTOR3 protects against the disease.

  • Humans4
  • Cells2

Upstream

1

LAMTOR3

downin silico1

1 study
  1. LAMTOR3 protects against cancer in silico.

    In silicop53-dependent

    Blind mole-rat mesenchymal stem cells resist carcinogen-induced damage through preserved p53 signaling · Stem cells (Dayton, Ohio) · 25 Sep 2026

LAMTOR3 →

Associations

2

Clonal hematopoiesis

upin humans1

1 study
  1. Clonal hematopoiesis is associated with cancer in humans.

    Review

    Telomeres in Aging: Links to Clonal Hematopoiesis, Cardiovascular Disease, and Cancer · The American journal of medicine · 29 Sep 2026

Clonal hematopoiesis →

Epigenetic alterations

upin humans1

1 study
  1. Epigenetic alterations raise the risk of cancer in humans.

    “Age-related epigenetic alterations can promote cancer, which exploits plasticity for evolution, immune evasion, metastasis, and resistance.”

    Review

    The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy · Genes · 16 Sep 2026

Epigenetic alterations →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 5Sep 2026: 29Oct 2026: 843